Open on EUR-Lex ↗
◷
New version applies from 02/01/2017. 8 provisions change. Later versions: 02/03/2017, 04/07/2017, 10/10/2017, 31/01/2018, 01/03/2018, 09/05/2018, 01/12/2018, 07/01/2019, 02/07/2019, 30/10/2019, 01/01/2020, 27/02/2020, 28/04/2020, 24/08/2020, 01/01/2021, 15/02/2021, 05/07/2021, 25/08/2021, 01/10/2021, 08/01/2022, 01/03/2022, 01/05/2022, 14/10/2022, 17/12/2022, 28/05/2023, 29/06/2023, 06/08/2023, 01/12/2023, 06/06/2024, 10/10/2024, 22/04/2025, 23/06/2025, 01/09/2025, 23/10/2025, 11/05/2026, 22/06/2026. Article 62 changes in this version: compare with the current text.

Article 62 - Applications for authorisations

Article 62
Applications for authorisations

1.An application for an authorisation shall be made to the Agency.

2.Applications for authorisation may be made by the manufacturer(s), importer(s) and/or downstream user(s) of the substance. Applications may be made by one or several persons.

3.Applications may be made for one or several substances, that meet the definition of a group of substances in Section 1.5 of Annex XI, and for one or several uses. Applications may be made for the applicant's own use(s) and/or for uses for which he intends to place the substance on the market.

4.An application for authorisation shall include the following information:

(a)

the identity of the substance(s), as referred to in Section 2 of Annex VI;

(b)

the name and contact details of the person or persons making the application;

(c)

a request for authorisation, specifying for which use(s) the authorisation is sought and covering the use of the substance in mixtures and/or the incorporation of the substance in articles, where this is relevant;

(d)

unless already submitted as part of the registration, a chemical safety report in accordance with Annex I covering the risks to human health and/or the environment from the use of the substance(s) arising from the intrinsic properties specified in Annex XIV;

(e)

an analysis of the alternatives considering their risks and the technical and economic feasibility of substitution and including, if appropriate information about any relevant research and development activities by the applicant;

(f)

where the analysis referred to in point (e) shows that suitable alternatives are available, taking into account the elements in Article 60(5), a substitution plan including a timetable for proposed actions by the applicant.

5.The application may include:

(a)

a socio-economic analysis conducted in accordance with Annex XVI;

(b)

a justification for not considering risks to human health and the environment arising either from:

(i)

emissions of a substance from an installation for which a permit was granted in accordance with Directive 96/61/EC; or

(ii)

discharges of a substance from a point source governed by the requirement for prior regulation referred to in Article 11(3)(g) of Directive 2000/60/EC and legislation adopted under Article 16 of that Directive.

6.The application shall not include the risks to human health arising from the use of a substance in a medical device regulated by Directives 90/385/EEC, 93/42/EEC or 98/79/EC.

7.An application for an authorisation shall be accompanied by the fee required in accordance with Title IX.

Official text · consolidated version 11/10/2016 (no longer in force) Open full page ↗
11 queries · page built in 39 msInventory f82bbfa3